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Comfrey (Symphytum officinale) has been used as a herbal medicine for >2000 years, 
mostly as a promoter of wound healing, analgesic and anti-inflammatory agent in 
musculoskeletal problems [1,2]. Although its molecular mechanism of action remains 
unclear, the efficacy of comfrey remedies has been confirmed in several clinical trials 
[3]. The aim of the research was to analyze and compare chemical composition of 
biologically active compounds, especially allantoin and phenolic compounds – simple 
phenols and flavonoids in comfrey roots and leaves obtained from different sources. 
Therefore, the TLC-densitometric method of allantoin determination was optimized. 
The analysis was carried out on TLC Si60 and TLC Si60F254 plates with the mobile phase: 
butanol-50 % methanol 2:1+0.16 mL HCOOH/60 mL of solvents mixture. The 
determined allantoin content varied from 0.35 to 2.17% in roots and was below the 
quantification limit in leaves. Moreover, the chemical profiles of analysed samples 
were compared with HPLC methods. As the result, quantification of phenolic acids was 
carried out (rosmarinic acid – in range of 0.59-1.84% in roots and 1.91-2.41% in leaves 
and caffeic acid – respectively 0.11-0.14% and 0.13-0.19%) and new glycosylated 
flavonoids in comfrey leaves were identified by the HPLC-DAD-MS. Antioxidant activity 
of both plant materials was compared with spectrophotometric assays (DPPH, ABTS 
and FRAP) and TLC-bioautography methods (DPPH, XO inhibition, riboflavin-light-NBT). 
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